Annual Shareholders Equity
$36.90 M
-$55.15 M-59.91%
December 31, 2023
Summary
- As of February 24, 2025, MRSN annual stockholders equity is $36.90 million, with the most recent change of -$55.15 million (-59.91%) on December 31, 2023.
- During the last 3 years, MRSN annual shareholders equity has fallen by -$191.18 million (-83.82%).
- MRSN annual shareholders equity is now -83.82% below its all-time high of $228.09 million, reached on December 31, 2020.
Performance
MRSN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$1.05 M
-$7.38 M-87.55%
September 30, 2024
Summary
- As of February 24, 2025, MRSN quarterly stockholders equity is $1.05 million, with the most recent change of -$7.38 million (-87.55%) on September 30, 2024.
- Over the past year, MRSN quarterly shareholders equity has stayed the same.
- MRSN quarterly shareholders equity is now -99.62% below its all-time high of $273.56 million, reached on June 30, 2020.
Performance
MRSN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
MRSN Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -59.9% | 0.0% |
| 3 y3 years | -83.8% | 0.0% |
| 5 y5 years | +319.6% | 0.0% |
MRSN Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -69.7% | at low | -99.3% | at low |
| 5 y | 5-year | -83.8% | at low | -99.6% | at low |
| alltime | all time | -83.8% | +166.3% | -99.6% | +101.5% |
Mersana Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.05 M(-87.6%) |
| Jun 2024 | - | $8.43 M(-69.9%) |
| Mar 2024 | - | $27.98 M(-24.2%) |
| Dec 2023 | $36.90 M(-59.9%) | $36.90 M(-29.3%) |
| Sep 2023 | - | $52.20 M(-41.9%) |
| Jun 2023 | - | $89.80 M(+39.7%) |
| Mar 2023 | - | $64.29 M(-30.2%) |
| Dec 2022 | $92.06 M(-24.4%) | $92.06 M(+2.0%) |
| Sep 2022 | - | $90.23 M(-32.7%) |
| Jun 2022 | - | $134.03 M(-4.6%) |
| Mar 2022 | - | $140.53 M(+15.4%) |
| Dec 2021 | $121.74 M(-46.6%) | $121.74 M(-21.7%) |
| Sep 2021 | - | $155.55 M(-20.4%) |
| Jun 2021 | - | $195.51 M(-1.2%) |
| Mar 2021 | - | $197.94 M(-13.2%) |
| Dec 2020 | $228.09 M | $228.09 M(-10.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $253.31 M(-7.4%) |
| Jun 2020 | - | $273.56 M(+333.6%) |
| Mar 2020 | - | $63.09 M(-19.4%) |
| Dec 2019 | $78.32 M(+790.5%) | $78.32 M(-15.8%) |
| Sep 2019 | - | $93.05 M(-14.3%) |
| Jun 2019 | - | $108.51 M(-12.5%) |
| Mar 2019 | - | $124.07 M(+1310.7%) |
| Dec 2018 | $8.79 M(-87.4%) | $8.79 M(-70.5%) |
| Sep 2018 | - | $29.85 M(-34.7%) |
| Jun 2018 | - | $45.69 M(-19.2%) |
| Mar 2018 | - | $56.55 M(-19.2%) |
| Dec 2017 | $69.99 M(-225.8%) | $69.99 M(-16.3%) |
| Sep 2017 | - | $83.64 M(-216.7%) |
| Jun 2017 | - | -$71.66 M(-330.1%) |
| Mar 2017 | - | $31.14 M(-156.0%) |
| Dec 2016 | -$55.62 M(+30.3%) | -$55.62 M |
| Dec 2015 | -$42.69 M | - |
FAQ
- What is Mersana Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Mersana Therapeutics?
- What is Mersana Therapeutics annual shareholders equity year-on-year change?
- What is Mersana Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Mersana Therapeutics?
- What is Mersana Therapeutics quarterly shareholders equity year-on-year change?
What is Mersana Therapeutics annual stockholders equity?
The current annual shareholders equity of MRSN is $36.90 M
What is the all time high annual shareholders equity for Mersana Therapeutics?
Mersana Therapeutics all-time high annual stockholders equity is $228.09 M
What is Mersana Therapeutics annual shareholders equity year-on-year change?
Over the past year, MRSN annual stockholders equity has changed by -$55.15 M (-59.91%)
What is Mersana Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of MRSN is $1.05 M
What is the all time high quarterly shareholders equity for Mersana Therapeutics?
Mersana Therapeutics all-time high quarterly stockholders equity is $273.56 M
What is Mersana Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, MRSN quarterly stockholders equity has changed by $0.00 (0.00%)